SUMMARY REPORT - WORKSHOP ON THE POTENTIAL RISKS OF ANTIBODY-DEPENDENT ENHANCEMENT IN HUMAN HIV VACCINE TRIALS

被引：73

作者：

MASCOLA, JR

MATHIESON, BJ

ZACK, PM

WALKER, MC

HALSTEAD, SB

BURKE, DS

机构：

[1] NIAID,DIV AIDS,VACCINE RES & DEV BRANCH,BETHESDA,MD 20892

[2] ROCKEFELLER FDN,DIV EYE DIS,NEW YORK,NY 10036

来源：

AIDS RESEARCH AND HUMAN RETROVIRUSES | 1993年 / 9卷 / 12期

关键词：

D O I：

10.1089/aid.1993.9.1175

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：1175 / 1184

页数：10

共 65 条

[11] INVITRO ENHANCEMENT OF RESPIRATORY SYNCYTIAL VIRUS-INFECTION OF U937-CELLS BY HUMAN-SERA [J].

GIMENEZ, HB ;

KEIR, HM ;

CASH, P .

JOURNAL OF GENERAL VIROLOGY, 1989, 70 :89-96

[12] ANTIBODY-DEPENDENT AND ANTIBODY-INDEPENDENT COMPLEMENT-MEDIATED ENHANCEMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION IN A HUMAN, EPSTEIN-BARR VIRUS-TRANSFORMED B-LYMPHOCYTIC CELL-LINE [J].

GRAS, GS ;

DORMONT, D .

JOURNAL OF VIROLOGY, 1991, 65 (01) :541-545

[13]

HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268

[14]

HALSTEAD SB, 1982, PROG ALLERGY, V31, P301

[15]

HALSTED SB, 1980, AM J TROP MED HYG, V29, P938

[16] STUDIES OF ANTIBODY-DEPENDENT ENHANCEMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) TYPE-1 INFECTION MEDIATED BY FC-RECEPTORS USING SERA FROM RECIPIENTS OF A RECOMBINANT GP160 EXPERIMENTAL HIV-1 VACCINE [J].

HAUBRICH, RH ;

TAKEDA, A ;

KOFF, W ;

SMITH, G ;

ENNIS, FA .

JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (03) :545-548

[17] SIMIAN IMMUNODEFICIENCY VIRUS-INFECTION OF MACAQUES - END-STAGE DISEASE IS CHARACTERIZED BY WIDESPREAD DISTRIBUTION OF PROVIRAL DNA IN TISSUES [J].

HIRSCH, VM ;

ZACK, PM ;

VOGEL, AP ;

JOHNSON, PR .

JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (05) :976-988

[18] SERUM ENHANCEMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION CORRELATES WITH DISEASE IN HIV-INFECTED INDIVIDUALS [J].

HOMSY, J ;

MEYER, M ;

LEVY, JA .

JOURNAL OF VIROLOGY, 1990, 64 (04) :1437-1440

[19] EFFICACY OF INACTIVATED WHOLE-VIRUS AND SUBUNIT VACCINES IN PREVENTING INFECTION AND DISEASE CAUSED BY EQUINE INFECTIOUS-ANEMIA VIRUS [J].

ISSEL, CJ ;

HOROHOV, DW ;

LEA, DF ;

ADAMS, WV ;

HAGIUS, SD ;

MCMANUS, JM ;

ALLISON, AC ;

MONTELARO, RC .

JOURNAL OF VIROLOGY, 1992, 66 (06) :3398-3408

[20] THE PRINCIPAL NEUTRALIZATION DETERMINANT OF SIMIAN IMMUNODEFICIENCY VIRUS DIFFERS FROM THAT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].

JAVAHERIAN, K ;

LANGLOIS, AJ ;

SCHMIDT, S ;

KAUFMANN, M ;

CATES, N ;

LANGEDIJK, JPM ;

MELOEN, RH ;

DESROSIERS, RC ;

BURNS, DPW ;

BOLOGNESI, DP ;

LAROSA, GJ ;

PUTNEY, SD .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (04) :1418-1422

← 1 2 3 4 5 6 7 →